| Literature DB >> 31889744 |
Francesco Muratori1, Nicola Mondanelli2, Xhulio Prifti1, Guido Scoccianti1, Giuliana Roselli3, Filippo Frenos1, Rodolfo Capanna4, Domenico Andrea Campanacci1.
Abstract
Total femur prosthesis (TFP) can be used in both oncological and prosthetic revision surgery. A retrospective analysis of 32 patients receiving a TFP at a single Center between 2002 and 2018 was performed. The average follow-up was 60 months. Revision implant free survival (RIFS) of the implants was 87% at 5 and 10 years and 72% at 15 years. Overall implant survival (OIS) of the prosthesis was 90% at 5, 10 and 15 years. Complications observed: two soft tissue failures, two infection failure and one tumor progression failure.Entities:
Keywords: Dislocation; Failure; Infectious; Total femur prosthesis; Tumor
Year: 2019 PMID: 31889744 PMCID: PMC6928329 DOI: 10.1016/j.jor.2019.11.009
Source DB: PubMed Journal: J Orthop ISSN: 0972-978X